With Evrysdi, ‘Everyday Is Good,’ Says 61-year-old With SMA Type 3
Jim Willison of Indiana talks about the gains he's made since starting with risdiplam (approved as Evrysdi) in the JEWELFISH clinical trial.
0 Comments
With Evrysdi, ‘Everyday Is Good,’ Says 61-year-old With SMA Type 3
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed